It looks like a great buy-and-hold option.

Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) and Abbott Laboratories (NYSE:ABT) both recently

Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wis

Andra AP fonden lowered its position in shares of Abbott Laboratories (NYSE: ABT) by 36.4% in the fi

AlTi Global Inc. lowered its stake in shares of Abbott Laboratories (NYSE: ABT) by 54.7% in the firs

Ascent Wealth Partners LLC reduced its stake in Abbott Laboratories (NYSE: ABT) by 29.4% during the

Assetmark Inc. grew its stake in shares of Abbott Laboratories (NYSE: ABT) by 8.9% during the first

AIA Group Ltd grew its position in shares of Abbott Laboratories (NYSE: ABT) by 49.8% in the first q

Allspring Global Investments Holdings LLC raised its stake in Abbott Laboratories (NYSE: ABT) by 11.

ABT's diversified diagnostics/nutrition/medtech segments drive multi-pronged growth prospects, as th

Abbott Laboratories is investigating two cyber incidents involving unauthorized access to ​some inte

Citigroup analyst Joanne Wuensch maintains Abbott Laboratories (NYSE:ABT) with a Buy and raises t

Piper Sandler analyst Adam Maeder reiterates Abbott Laboratories (NYSE:ABT) with a Overweight and

Abbott's raised 2026 earnings outlook and four growth drivers point to a faster second half across n

JP Morgan analyst Robbie Marcus maintains Abbott Laboratories (NYSE:ABT) with a Overweight and ra

Wells Fargo analyst Larry Biegelsen maintains Abbott Laboratories (NYSE:ABT) with a Overweight an

TD Cowen analyst Joshua Jennings reiterates Abbott Laboratories (NYSE:ABT) with a Buy and maintai

Abbott Laboratories (NYSE:ABT) reported upbeat second-quarter results and raised its full-year adjus

Abbott Laboratories (NYSE:ABT) reported strong Q2 results, raising its full-year earnings outlook. A

Evercore ISI Group analyst Vijay Kumar maintains Abbott Laboratories (NYSE:ABT) with a Outperform

RBC Capital analyst Shagun Singh reiterates Abbott Laboratories (NYSE:ABT) with a Outperform and

Compass Pathways (NASDAQ:CMPS)'s COMP360 treatment model may face fewer regulatory hurdles as new Ph

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analys

Recent analyst rating changes, top names such as PPG, SAH, ISRG, MMM, OKE, GLDG, ABT, NFLX, TSCO, an

ISRG stock drops 11% as Intuitive Surgical beats Q2 estimates but warns insurance changes could slow

Abbott Laboratories has rallied sharply since my last "Buy" rating in May. Strength in its core Medi

BTIG analyst Marie Thibault maintains Abbott Laboratories (NYSE:ABT) with a Buy and raises the pr

Abbott Laboratories (NYSE: ABT - Get Free Report) shares gapped up before the market opened on Thurs

Market sentiment declined as stocks fell, with tech stocks leading the way. UnitedHealth Group and A

Demand for Abbott's medical devices and diagnostic tests is rising. The company has increased its di

Abbott Laboratories NYSE: ABT gave the market what it wanted in its Q2 earnings report, affirming th

Abbott Laboratories (ABT) Q2 2026 Earnings Call Transcript

Abbott (ABT) stock jumps 12% after beating Q2 2026 earnings and revenue estimates and raising its fu

A semiconductor selloff sank the Nasdaq 100 more than 1% while UnitedHealth's blowout quarter li

Why is the Dow holding up while the Nasdaq sinks? Healthcare gains are offsetting the semiconductor

ABT tops Q2 earnings and revenue estimates and lifts 2026 EPS guidance, while Medical Devices and Ca

Abbott Laboratories (NYSE:ABT) shares rose nearly 11% on Thursday after the healthcare company repor

4:15pm: Semiconductor selloff Wall Street ended lower on Thursday, with semiconductor stocks leading

The Dow and Russell 2000 are higher today, while the S&P 500 and Nasdaq move lower alongside chip st

Abbott Laboratories delivered strong Q2 results, beating expectations and raising FY 2026 guidance,

Abbott Laboratories NYSE: ABT reported second-quarter 2026 comparable sales growth of 4.8% and adjus

Abbott Laboratories stock surged over 13% Thursday after second-quarter earnings topped estimates an

Although the revenue and EPS for Abbott (ABT) give a sense of how its business performed in the quar

Abbott Laboratories (NYSE:ABT) released second-quarter financial results and hosted an earnings call

U.S. stocks were mixed, with the Nasdaq Composite falling around 150 points on Thursday.

U.S. stocks mixed, Nasdaq falls 150 points. Abbott Labs beats Q2 estimates and raises guidance, sto

Abbott (ABT) came out with quarterly earnings of $1.31 per share, beating the Zacks Consensus Estima

The healthcare company said its profit fell to $928 million, or 53 cents a share, in the second quar

11:50am: AI stocks out of favor Investors are still favoring stocks with little direct exposure to A

The market still treats Abbott Laboratories (NYSE:ABT | ABT Price Prediction) like a bond proxy with